𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Brain perfusion effects of cholinesterase inhibitors in Parkinson’s disease with dementia

✍ Scribed by R. Ceravolo; D. Volterrani; D. Frosini; S. Bernardini; C. Rossi; C. Logi; G. Manca; L. Kiferle; G. Mariani; L. Murri; U. Bonuccelli

Book ID
106206982
Publisher
Springer
Year
2006
Tongue
English
Weight
87 KB
Volume
113
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ventricular dilatation and brain atrophy
Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia
✍ Richard Camicioli; Jennifer Sabino; Myrlene Gee; Thomas Bouchard; Nancy Fisher; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB

## Abstract Age‐related ventricular enlargement is accelerated in Alzheimer's disease, but its relationship to cognitive decline in Parkinson's disease is less clear, even though dementia is common in Parkinson's disease. Our goals were to determine if greater enlargement of the ventricles and gray

Economic evaluation of cholinesterase in
Economic evaluation of cholinesterase inhibitor therapy for dementia: comparison of Alzheimer's disease and Dementia with Lewy bodies
✍ Anders Gustavsson; Rohan Van Der Putt; Linus Jönsson; Rupert McShane 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## Abstract ## Objective To assess the cost effectiveness of cholinesterase inhibitor (ChEI) treatment in patients with Alzheimer's disease (AD) and Dementia with Lewy bodies (DLB). ## Method We used 4‐month open label follow‐up data from routine memory clinic patients. There were 852 patients w